Form S-3/A SAB Biotherapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- S&P 500, Nasdaq drop as tech megacap declines outweigh upbeat Micron forecast
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
SAB Biotherapeutics (SABS) files for up to 250M share offering by selling stockholders
September 22, 2025 5:18 PM EDTSAB Biotherapeutics (NASDAQ: SABS) has filed for up to 250,000,000 share offering by selling stockholders.
... More